344 related articles for article (PubMed ID: 20388706)
1. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
[TBL] [Abstract][Full Text] [Related]
2. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
Zhao D; Zheng HQ; Zhou Z; Chen C
Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
[TBL] [Abstract][Full Text] [Related]
3. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
Bialkowska AB; Liu Y; Nandan MO; Yang VW
J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
5. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
6. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
[TBL] [Abstract][Full Text] [Related]
7. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.
Cassavaugh JM; Hale SA; Wellman TL; Howe AK; Wong C; Lounsbury KM
J Cell Biochem; 2011 Dec; 112(12):3882-90. PubMed ID: 21964756
[TBL] [Abstract][Full Text] [Related]
9. FBW7-mediated ubiquitination and degradation of KLF5.
Luan Y; Wang P
World J Biol Chem; 2014 May; 5(2):216-23. PubMed ID: 24921010
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin ligase Fbw7 restricts the replication of hepatitis C virus by targeting NS5B for ubiquitination and degradation.
Chen J; Wu X; Chen S; Chen S; Xiang N; Chen Y; Guo D
Biochem Biophys Res Commun; 2016 Feb; 470(3):697-703. PubMed ID: 26774344
[TBL] [Abstract][Full Text] [Related]
11. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α.
Flügel D; Görlach A; Kietzmann T
Blood; 2012 Feb; 119(5):1292-301. PubMed ID: 22144179
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1.
Biswas M; Kwong EK; Park E; Nagra P; Chan JY
Exp Cell Res; 2013 Aug; 319(13):1922-1931. PubMed ID: 23623971
[TBL] [Abstract][Full Text] [Related]
15. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
Biswas M; Phan D; Watanabe M; Chan JY
J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
[TBL] [Abstract][Full Text] [Related]
16. FBW7 targets KLF10 for ubiquitin-dependent degradation.
Yu S; Wang F; Tan X; Gao GL; Pan WJ; Luan Y; Ge X
Biochem Biophys Res Commun; 2018 Jan; 495(2):2092-2097. PubMed ID: 29198712
[TBL] [Abstract][Full Text] [Related]
17. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4.
Welcker M; Clurman BE
J Biol Chem; 2005 Mar; 280(9):7654-8. PubMed ID: 15611062
[TBL] [Abstract][Full Text] [Related]
18. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
19. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
Trausch-Azar JS; Abed M; Orian A; Schwartz AL
J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.
Isobe T; Hattori T; Kitagawa K; Uchida C; Kotake Y; Kosugi I; Oda T; Kitagawa M
J Biol Chem; 2009 Oct; 284(41):27766-27779. PubMed ID: 19679664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
